Herein, we found that indomethacin enhances anti‐tumour immune responses, including increasing CD8+ T cell population and IFNγ secretion in a humanized mouse model, implying indomethacin plays a vital role in the tumour microenvironment and may be a potential anti‐immunosuppressive strategy. Here, IFNG is linked to neoplasm.